BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 31450675)

  • 1. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer.
    Koliarakis I; Messaritakis I; Nikolouzakis TK; Hamilos G; Souglakos J; Tsiaoussis J
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Intestinal Microbiota and Colorectal Cancer.
    Cheng Y; Ling Z; Li L
    Front Immunol; 2020; 11():615056. PubMed ID: 33329610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
    Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
    Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis signature of mycobiota in colon polyp and colorectal cancer.
    Gao R; Kong C; Li H; Huang L; Qu X; Qin N; Qin H
    Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2457-2468. PubMed ID: 28821976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota and colorectal cancer: a new aspect of research.
    Koliarakis I; Psaroulaki A; Nikolouzakis TK; Kokkinakis M; Sgantzos MN; Goulielmos G; Androutsopoulos VP; Tsatsakis A; Tsiaoussis J
    J BUON; 2018; 23(5):1216-1234. PubMed ID: 30512251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial protection and virulence in periodontal tissue as a function of polymicrobial communities: symbiosis and dysbiosis.
    Roberts FA; Darveau RP
    Periodontol 2000; 2015 Oct; 69(1):18-27. PubMed ID: 26252399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oral microbiota: dynamic communities and host interactions.
    Lamont RJ; Koo H; Hajishengallis G
    Nat Rev Microbiol; 2018 Dec; 16(12):745-759. PubMed ID: 30301974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into oral microbiome and colorectal cancer - on the way of searching new perspectives.
    Kudra A; Muszyński D; Sobocki BK; Atzeni A; Carbone L; Kaźmierczak-Siedlecka K; Połom K; Kalinowski L
    Front Cell Infect Microbiol; 2023; 13():1159822. PubMed ID: 37124035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.